[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 117,879,344
  • Shares Outstanding, K 1,280,045
  • Annual Sales, $ 36,364 M
  • Annual Income, $ 4,800 M
  • EBIT $ 8,238 M
  • EBITDA $ 11,196 M
  • 60-Month Beta 0.55
  • Price/Sales 3.19
  • Price/Cash Flow 11.63
  • Price/Book 2.34

Options Overview Details

View History
  • Implied Volatility 30.23% (+0.75%)
  • Historical Volatility 26.92%
  • IV Percentile 92%
  • IV Rank 70.47%
  • IV High 36.98% on 06/02/26
  • IV Low 14.14% on 12/09/25
  • Expected Move (DTE 2) 1.60 (1.74%)
  • Put/Call Vol Ratio 0.30
  • Today's Volume 10,729
  • Volume Avg (30-Day) 12,655
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 250,358
  • Open Int (30-Day) 226,187
  • Expected Range 90.49 to 93.69

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 07/31/26
See More
  • Average Estimate $1.38
  • Number of Estimates 8
  • High Estimate $1.39
  • Low Estimate $1.36
  • Prior Year $1.26
  • Growth Rate Est. (year over year) +9.52%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.49 +13.01%
on 07/21/26
93.09 -1.07%
on 08/18/26
+8.89 (+10.69%)
since 07/17/26
3-Month
73.31 +25.62%
on 06/02/26
93.09 -1.07%
on 08/18/26
+14.77 (+19.10%)
since 05/18/26
52-Week
73.31 +25.62%
on 06/02/26
106.33 -13.39%
on 11/26/25
-0.72 (-0.78%)
since 08/18/25

Most Recent Stories

More News
Orchestra BioMed Reports Second Quarter 2026 Financial Results and Highlights Recent Business Updates

The BACKBEAT global pivotal trial (“BACKBEAT Trial”), conducted in collaboration with Medtronic, is on track to reach its target of 284 evaluable randomized patients by end of Q3 2026, with primary...

MDT : 92.09 (+1.64%)
OBIO : 5.66 (+19.92%)
Medtronic announces expanded CE Mark indication for Affera™ Mapping and Ablation System and Sphere-9™ Catheter for treatment of ventricular arrhythmias

Sphere-9 all-in-one mapping and ablation, large-tip focal, dual energy catheter first to be CE Marked for ventricular ablation

MDT : 92.09 (+1.64%)
Do Wall Street Analysts Like Medtronic Stock?

Medtronic has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

NVDA : 219.74 (-2.34%)
$SPX : 7,691.76 (-0.69%)
IHI : 55.44 (+0.65%)
MMED : 19.36 (-0.87%)
MDT : 92.09 (+1.64%)
J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.

J&J’s Ottava clearance knocked Intuitive's shares lower, but recurring revenue and surgeon switching costs suggest the market overreacted.

JNJ : 271.11 (+3.33%)
IHI : 55.44 (+0.65%)
MDT : 92.09 (+1.64%)
ISRG : 391.18 (+0.22%)
Medtronic Earnings Preview: What to Expect

: Medtronic is set to report Q1 earnings, with analysts expecting high single-digit year-over-year EPS growth.

NVDA : 219.74 (-2.34%)
XLV : 169.73 (+1.60%)
$SPX : 7,691.76 (-0.69%)
MDT : 92.09 (+1.64%)
A new era for surgery with real-time AI: Medtronic to unveil Touch Surgery™ Aide, the next-generation compute platform for the operating room at Society of Robotic Surgery 2026

Advanced compute power, built on NVIDIA infrastructure, enables real-time decision support during the procedure

MDT : 92.09 (+1.64%)
Medtronic to announce financial results for its first quarter of fiscal year 2027

GALWAY, Ireland , July 20, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Tuesday, September 1,...

MDT : 92.09 (+1.64%)
Why Intuitive Surgical’s Strong Quarter Still Spooked Investors

Intuitive Surgical shares fell about 10% after Q2 2026 revenue rose 19% but guidance for da Vinci procedure growth wasn't raised, pushing ISRG below its 200-week moving average.

BSX : 50.47 (-1.87%)
HCA : 411.73 (+1.67%)
MDT : 92.09 (+1.64%)
ISRG : 391.18 (+0.22%)
Medtronic completes acquisition of SPR, expanding patient access to minimally invasive, non-opioid treatment of chronic and acute pain

Acquisition adds category-defining SPRINT® PNS technology to Medtronic's pain therapy portfolio—the broadest in the industry.¹

MDT : 92.09 (+1.64%)
Cerebras Stock Offers a Clear Warning that Highly Anticipated IPOs from OpenAI and Anthropic Could Crash Back to Earth Fast

IPOs are the new meme stocks, surging to record highs before crashing below their debut prices in a matter of days.

SPCX : 143.34 (-1.98%)
DUK : 123.99 (+0.33%)
MDT : 92.09 (+1.64%)
CBRS : 220.01 (-12.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

Relative Strength just crossed above 70%. The market has entered overbought territory.

See More Share

Business Summary

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience...

See More

Key Turning Points

3rd Resistance Point 94.59
2nd Resistance Point 93.84
1st Resistance Point 92.96
Last Price 92.09
1st Support Level 91.34
2nd Support Level 90.59
3rd Support Level 89.72

See More

52-Week High 106.33
Fibonacci 61.8% 93.72
Last Price 92.09
Fibonacci 50% 89.82
Fibonacci 38.2% 85.92
52-Week Low 73.31

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.